{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:56:50Z","timestamp":1781218610803,"version":"3.54.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adenomyosis occurs when tissue from the inner lining of the endometrium grows into the muscle wall of the myometrium. Previous studies have suggested that High-Intensity Focused Ultrasound (HIFU) combined with medications may improve treatment outcomes for adenomyosis; however, the comparative efficacy of different medication combinations remains unclear. This network meta-analysis aimed to compare and rank the efficacy of various medications combined with HIFU in patients with adenomyosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomized controlled trials reporting on HIFU combined with medications for adenomyosis were retrieved from 8 databases from their inception to 23 June 2025. The literature meeting the inclusion criteria was evaluated for quality and risk of bias using the Cochrane 5.1 manual and RoB2. Subsequently, a Bayesian network meta-analysis was conducted using R software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of six interventions (HIFU + GnRH-a, HIFU + testosterone propionate, HIFU + percutaneous ethanol injection, HIFU + microbubble contrast agent, HIFU + oxytocin, and HIFU + microbubble contrast agent + oxytocin) were included to evaluate their efficacy on intraoperative indicators of adenomyosis compared with HIFU alone. A total of 8,700 records were retrieved, with 16 studies ultimately included, involving 1,685 patients with adenomyosis. Compared with HIFU alone, HIFU combined with ethanol ablation demonstrated the highest efficacy in non-perfused volume ratios (NPVR) (Mean Difference (MD) = 27, 95% Confidence Interval (CI): 2.7 to 52), sonication energy (MD = \u2212230%, 95% CI: \u2212290 to \u2212180), and treatment duration (MD = \u221244%, 95% CI: \u221280 to \u22127.8); Additionally, HIFU combined with Gonadotropin-releasing hormone agonist (GnRH-a) showed superiority in energy efficiency factor (MD = \u221231%, 95% CI: \u221290 to \u221213).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The efficacy of HIFU combined with medications in the treatment of adenomyosis is superior to that of HIFU alone. Different medications offer distinct advantages in enhancing the therapeutic effect of HIFU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>clinicaltrials.gov<\/jats:ext-link>\n                      , identifier CRD420251143604.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1767202","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:10:15Z","timestamp":1781215815000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy of ultrasonic ablation combined with medication in the treatment of adenomyosis: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Qi","family":"Qin","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Changchun University of Traditional Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Diagnosis and Treatment Center, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Pang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[{"name":"Research Center of Traditional Chinese Medicine, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Diagnosis and Treatment Center, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17455057241295593","DOI":"10.1177\/17455057241295593","article-title":"High-intensity focused ultrasound in adenomyosis treatment: insights on safety, efficacy, and reproductive prospects","volume":"20","author":"Bahutair","year":"2024","journal-title":"Womens Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.16118\/j.1008-0392.2017.02.011","article-title":"Intensity focused ultrasound combined with GnRH a for treatment ofuterine adenomyosis: A dosimetric study","volume":"38","author":"Cao Zhengjun","year":"2017","journal-title":"J. Tongji Univ. Med. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"102507","DOI":"10.1016\/j.bpobgyn.2024.102507","article-title":"Conservative surgical treatment for adenomyosis: new options for looking beyond uterus removal","volume":"95","author":"Capezzuoli","year":"2024","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1124\/pr.120.019398","article-title":"Is oxytocin Nature's Mmdicine","volume":"72","author":"Carter","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1088\/0031-9155\/57\/4\/937","article-title":"Effect of ethanol injection on cavitation and heating of tissues exposed to high-intensity focused ultrasound","volume":"57","author":"Chen","year":"2012","journal-title":"Phys. Med. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1077145","DOI":"10.3389\/fbioe.2022.1077145","article-title":"Microbubble contrast agent SonoVue: an efficient medium for the preoperative lymphatic mapping of thyroid carcinoma","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2418426","DOI":"10.1080\/02656736.2024.2418426","article-title":"Pilot study on the impact of HIFU treatment on miRNA profiles in vaginal secretions of uterine fibroids and adenomyosis patients","volume":"41","author":"Chen","year":"2024","journal-title":"Int. J. Hyperth."},{"key":"B8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3969\/j.issn.1009-4393.2023.31.018","article-title":"Effectiveness and safety analysis of microbubbleultrasound contrast agent assisted high intensity focusedultrasound in the treatment of adenomyosis","volume":"29","author":"Chen Meiqin","year":"2023","journal-title":"Contemp. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/1471-0528.14744","article-title":"Enhancing ablation effects of a microbubble contrast agent on high-intensity focused ultrasound: an experimental and clinical study","volume":"124","author":"Cheng","year":"2017","journal-title":"BJOG"},{"key":"B10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.16245\/j.cnki.issn1008-6978.2019.05.027","article-title":"Clinical value of high intensity focused ultrasound combined with percutaneous ethanol injection in treatment of adenomyosis","volume":"21","author":"Ding Guisheng","year":"2019","journal-title":"J. Clin. Ultrasound Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/GCO.0b013e32833bea2e","article-title":"High-intensity focused ultrasound ablation of uterine localized adenomyosis","volume":"22","author":"Dong","year":"2010","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bpobgyn.2018.01.016","article-title":"Minimally invasive treatment of adenomyosis","volume":"51","author":"Dueholm","year":"2018","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B13","first-page":"538","article-title":"Treatment of adenomyosis with long-term GnRH analogues: a case report","volume":"78","author":"Grow","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/OGX.0000000000000346","article-title":"The impact of adenomyosis on women's fertility","volume":"71","author":"Harada","year":"2016","journal-title":"Obstet. Gynecol. Surv."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S729","DOI":"10.1016\/j.ajog.2023.06.041","article-title":"Oxytocin: physiology, pharmacology, and clinical application for labor management","volume":"230","author":"Hermesch","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ultsonch.2015.05.027","article-title":"Using microbubble sonographic contrast agent to enhance the effect of high intensity focused ultrasound for the treatment of uterine fibroids","volume":"27","author":"Isern","year":"2015","journal-title":"Ultrason. Sonochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.tjog.2020.09.013","article-title":"500 cases of high-intensity focused ultrasound (HIFU) ablated uterine fibroids and adenomyosis","volume":"59","author":"Jeng","year":"2020","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3969\/j.issn.1674-4020.2023.05.19","article-title":"Evaluation of the effect of pretreatment with GnRH-a before HIUtreatment for severe adenomyosis","volume":"15","author":"Jia Xiao-Ping","year":"2023","journal-title":"Chin. J. Fam. Plan. Obstetrics and Gynecol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/01.rli.0000199292.88189.0f","article-title":"Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications","volume":"41","author":"Klibanov","year":"2006","journal-title":"Invest Radiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.endien.2023.08.007","article-title":"Percutaneous ethanol injection in thyroid nodular pathology and metastatic cervical adenopathies: a systematic review, meta-analysis and economic evaluation. Endocrinol","volume":"70","author":"Le\u00f3n-Salas","year":"2023","journal-title":"Diabetes Nutr."},{"key":"B21","first-page":"839","article-title":"Study on therapeutic dosimetry of HIFU ablation tissue","volume":"23","author":"Li","year":"2006","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3969\/j.issn.1672-0369.2021.22.021","article-title":"Effects of absolute ethanol injection combined with high intensity focused ultrasound in treatment of patients with adenomyosis","volume":"33","author":"Li Fengli","year":"2021","journal-title":"China J. Health Psychol."},{"key":"B23","first-page":"12","article-title":"Observation on the application value of testosterone propionate in high-intensity focused ultrasound treatment for adenomyosis","volume":"2016","author":"Lingxian","year":"2016","journal-title":"Maternal Child World"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/humrep\/des332","article-title":"How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic","volume":"27","author":"Naftalin","year":"2012","journal-title":"Hum. Reprod."},{"key":"B25","doi-asserted-by":"publisher","first-page":"eadp7206","DOI":"10.1126\/science.adp7206","article-title":"Exploiting the mechanical effects of ultrasound for noninvasive therapy","volume":"385","author":"O'Reilly","year":"2024","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"688264","DOI":"10.3389\/fpubh.2021.688264","article-title":"Efficacy of high-intensity focused ultrasound combined with GnRH-a for adenomyosis: a systematic review and meta-analysis","volume":"9","author":"Pang","year":"2021","journal-title":"Front. Public Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1080\/02656736.2021.1967467","article-title":"Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results","volume":"38","author":"Peng","year":"2021","journal-title":"Int. Journal Hyperthermia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/molehr\/gah039","article-title":"Oxytocin receptor gene expression of estrogen-stimulated human myometrium in extracorporeally perfused non-pregnant uteri","volume":"10","author":"Richter","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1080\/02656736.2021.1993357","article-title":"Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis","volume":"38","author":"Ruihong","year":"2021","journal-title":"Int. Journal Hyperthermia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3969\/j.issn.1672-1993.2024.09.018","article-title":"Clinical efficacy of GnRH-a pretreatment combined with HIFU ablation in the treatment of diffuse adenomyosis","volume":"33","author":"Song Xuewei","year":"2024","journal-title":"Chin. J. Sexology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000148026","article-title":"The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis","volume":"66","author":"Tesone","year":"2008","journal-title":"Gynecol. Obstet. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/s-0040-1718920","article-title":"Epidemiology of adenomyosis","volume":"38","author":"Upson","year":"2020","journal-title":"Semin. Reprod. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3969\/j.issn.0253-9802.2020.07.012","article-title":"Clinical value of sulfur hexafluoride microbubbles in HIFU treatment of uterine adenomyosis","volume":"51","author":"Wang Yi","year":"2020","journal-title":"New Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3969\/j.issn.1004-8189.2022.03.012","article-title":"Clinical efficacy and safety of leuprorelin combined with high intensity focused ultrasound for treating adenomyosis","volume":"30","author":"Wu Na","year":"2022","journal-title":"Chin. J. Fam. Plan."},{"key":"B35","first-page":"100+102","article-title":"Application of oxytocin in ultrasound ablation treatment for 48 cases of adenomyosis","volume":"25","author":"Wu Xiangrong","year":"2016","journal-title":"Chin. Ethn. Med. Folk Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.14035\/j.cnki.hljyy.2018.04.047","article-title":"Analysis of the efficacy and advantages of oxytocin application in ultrasound ablation therapy for adenomyosis","volume":"31","author":"Xiaoli","year":"2018","journal-title":"Heilongjiang Med. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jmig.2017.07.014","article-title":"Conservative surgery for adenomyosis and results: A systematic review","volume":"25","author":"Younes","year":"2018","journal-title":"J. Minim. Invasive Gynecol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"94.e1","DOI":"10.1016\/j.ajog.2020.01.016","article-title":"Adenomyosis incidence, prevalence and treatment: united States population-based study 2006-2015","volume":"223","author":"Yu","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.ejrad.2014.05.008","article-title":"Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: A prospective study","volume":"83","author":"Zhang","year":"2014","journal-title":"Eur. J. Radiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.21037\/apm-22-602","article-title":"The safety and efficacy of add-on use of oxytocin in uterine leiomyoma patients undergoing high-intensity focused ultrasound and ultrasound-guided intratumoral ethanol injection: A randomized controlled trial","volume":"11","author":"Zhang","year":"2022","journal-title":"Ann. Palliat. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.16190\/j.cnki.45-1211\/r.2021.12.024","article-title":"Clinical efficacy of high-intensity focused ultrasound ablation combined with GnRH-a in the treatment of diffuse adenomyosis","volume":"38","author":"Zhang Ting","year":"2021","journal-title":"J. Guangxi Med. Univ."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.3969\/j.issn.1671-8348.2012.36.010","article-title":"Effeets of oxytocin on high intensity focused ultrasound ablation of adenomysis","volume":"41","author":"Zhang Xin","year":"2012","journal-title":"Chongqing Med."},{"key":"B43","first-page":"103","article-title":"Dose-effect research on the effect of oxytocin on high intensity focused ultrasound ablation of adenomysis","volume":"34","author":"Zhang Xin","year":"2013","journal-title":"J. Lasers."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1767202\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:10:22Z","timestamp":1781215822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1767202\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":43,"alternative-id":["10.3389\/fphar.2026.1767202"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1767202","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"article-number":"1767202"}}